Literature DB >> 11504517

Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.

H K Kim1, I A Park, D S Heo, D Y Noh, K J Choe, Y J Bang, N K Kim.   

Abstract

AIM: Prognostic value of the cyclin E overexpression in breast cancer has not been clearly established, especially in relation to the pattern of recurrence. We investigated the implication of cyclin E overexpression for the pattern of recurrence in Korean breast cancer patients.
METHODS: Using immunohistochemical methods, we retrospectively examined the cyclin E expression level in breast cancer specimens from 128 women who underwent curative breast surgery, and correlated the levels of expression with the pattern of relapse in patients.
RESULTS: Cox model-based multivariate analysis indicated that distant relapse could be predicted by the number of positive axillary lymph nodes, high cyclin E expression, and the younger age (<35 years) of the patient. We tested further the association of cyclin E overexpression with the specific types of recurrence; multivariate analyses indicated that adjusted relative risks of bone and visceral relapse as the first events among high cyclin E group were 2.46 (95% confidence interval (CI), 0.86-7.02) (P=0.092), and 3.98 (95% CI, 1.23-12.94) (P=0.022), respectively. On the other hand, cyclin E overexpression was not associated with the risk of locoregional relapse.
CONCLUSION: Our data suggest that cyclin E overexpression in primary breast carcinoma tissue could independently predict the risk of distant relapse, especially of visceral relapse, as the first failure after curative breast surgery. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504517     DOI: 10.1053/ejso.2001.1137

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.

Authors:  Komala Pillay; Heather McCleod; Runjan Chetty; Pauline Hall
Journal:  World J Surg Oncol       Date:  2011-03-16       Impact factor: 2.754

2.  Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Authors:  Pankaj Taneja; Dejan Maglic; Fumitake Kai; Sinan Zhu; Robert D Kendig; Elizabeth A Fry; Kazushi Inoue
Journal:  Clin Med Insights Oncol       Date:  2010-04-20

3.  Prognostic value of cyclin E expression in breast cancer: a meta-analysis.

Authors:  Sheng Gao; Jing-Jing Ma; Cheng Lu
Journal:  Tumour Biol       Date:  2013-06-18

4.  Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

Authors:  Cansu Karakas; Anna Biernacka; Tuyen Bui; Aysegul A Sahin; Min Yi; Said Akli; Jolie Schafer; Angela Alexander; Opoku Adjapong; Kelly K Hunt; Khandan Keyomarsi
Journal:  Am J Pathol       Date:  2016-05-13       Impact factor: 4.307

5.  Cyclin E deregulation is an early event in the development of breast cancer.

Authors:  Alexandra Shaye; Aysegul Sahin; Qiang Hao; Kelly Hunt; Khandan Keyomarsi; Isabelle Bedrosian
Journal:  Breast Cancer Res Treat       Date:  2008-12-24       Impact factor: 4.872

6.  Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

Authors:  Anders Ström; Johan Hartman; James S Foster; Silke Kietz; Jay Wimalasena; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

7.  Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.

Authors:  Satu Luhtala; Synnöve Staff; Minna Tanner; Jorma Isola
Journal:  Tumour Biol       Date:  2016-01-26

Review 8.  Measuring proliferation in breast cancer: practicalities and applications.

Authors:  Mark J Beresford; George D Wilson; Andreas Makris
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

Review 9.  CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.

Authors:  Patrizia Bonelli; Franca Maria Tuccillo; Antonella Borrelli; Antonietta Schiattarella; Franco Maria Buonaguro
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

10.  Protein expression patterns of cell cycle regulators in operable breast cancer.

Authors:  Flora Zagouri; Vassiliki Kotoula; George Kouvatseas; Maria Sotiropoulou; Triantafyllia Koletsa; Theofani Gavressea; Christos Valavanis; Helen Trihia; Mattheos Bobos; Georgios Lazaridis; Angelos Koutras; George Pentheroudakis; Pantelis Skarlos; Dimitrios Bafaloukos; Niki Arnogiannaki; Sofia Chrisafi; Christos Christodoulou; Pavlos Papakostas; Gerasimos Aravantinos; Paris Kosmidis; Charisios Karanikiotis; George Zografos; Christos Papadimitriou; George Fountzilas
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.